EVERSANA has added another feature to its ORCHESTRATE platform for the commercialisation of life science products – an ...

Incyte's infringement lawsuit is claiming that Sun Pharma's drug infringes a US patent (No. 9,662,335) it holds on the use of ...

The first targeted drug for a common form of bladder cancer that can be taken at home has been backed for NHS use, offering hope of simpler treatment to hundreds of patients in England. The oral drug ...

For Reuters Pharma Europe 2025, pharmaphorum is providing coverage courtesy NAVLIN Daily, a pricing and market access ...

A notice posted by the NIH in February said the agency would slash its funding of indirect costs borne by research teams at ...

Soliris contributed $2.58 billion in global revenues to AZ last year, a 14% drop on the prior year, of which just over $1.4 ...

During a fireside chat at Reuters Pharma Europe 2025, Francesco Di Marco, Global Head of Human Pharma Regions at Boehringer ...

In a fitting embodiment of its own themes, this year, Reuters Pharma Europe 2025 is offering an AI-generated summary of each ...

Jazz Pharma has agreed to pay $145 million to settle lawsuits claiming it illegally acted to prevent generic versions of its ...

The FDA has approved Bristol Myers Squibb's Opdivo and Yervoy as first-line therapy for patients with a particular form of ...

The team from Cancer Research UK's Manchester Institute says it has created a new in vitro model of lung squamous cell ...

The US is dangerously close to falling behind China in biotech, and the government should spend a minimum of $15 billion over ...